Verdict Medical Devices

GeneCentric advances precision oncology with new liquid biopsy platform

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform. The post GeneCentric advances precision oncology with new liquid biopsy platform appeared first on Medical Device Network.

Jun 20, 2025 - 18:20
 0
GeneCentric advances precision oncology with new liquid biopsy platform
GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform.

The post GeneCentric advances precision oncology with new liquid biopsy platform appeared first on Medical Device Network.

Read More

Tags:

Previous Article

Penumbra may gain market share in peripheral embolisation coils with Ruby XL

Next Article

Neuspera secures FDA approval for urinary incontinence implantable

Related Posts

Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes

Novo Nordisk seeks digital health partners to boost GLP...

Jun 18, 2025  0

Intalight gains CE mark approval for DREAM OCT platform

Intalight gains CE mark approval for DREAM OCT platform

May 16, 2025  0

Terumo Neuro launches new neurovascular catheter in US

Terumo Neuro launches new neurovascular catheter in US

May 15, 2025  0